RE:RE:RE:Seems frothyQContinuum1 wrote: If a 400M Euro medical market in Germany isn't enough for Medipharm or it's numerous partners in Germany (one being a massive one), then I don't know how much would be enough.
There is no excuse for Medipharm to not be achieving $10M CDN alone from Germany. None.
now i am beginning to think all the price action and volume as of late has everything to do with Germany
Not sure about all the others selling into the german market but with Strada being our partner with their presence and being a known entity to the helth care professionals over there i would think they would be the leaders in tearms of sales.
if I were a doctor and inclined to write prescriptions for canabis med's who would i choose to go with ... a known entity like Strada and their record especially when it comes to drugs, safety and a well known name or some out of country player that they may have never heard of that includes Tillray.
if a patient is eligable i would perscribe a Strada backed Product before anyone elses .
I DK but sure makes sense to me
the change in the law that was posted shows what types of Doctors can perscribe the Canabis products to their patients and that it only requires the regular prescription type to have the cost covered by the govenment